Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer

Journal of Clinical Oncology

Volumn 27, Issue 3, 2009, Pages 344-351

  Segal, Roanne J ^a   Reid, Robert D ^a   Courneya, Kerry S ^a   Sigal, Ronald J ^a   Kenny, Glen P ^a   Prud'Homme, Denis G ^a   Malone, Shawn C ^a   Wells, George A ^a   Scott, Chris G ^a   Slovinec D'Angelo, Monika E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FITNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE TRAINING; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; EXERCISE; EXERCISE TOLERANCE; FATIGUE; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TRIGLYCERIDES;

EID: 58549096519     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.4963     Document Type: Article

References (25)

1. American Cancer Society: Cancer Facts and Figures 2007. Atlanta, GA, 2007
2. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2007. Canadian Cancer Society/National Cancer Institute of Canada, Toronto, Ontario, Canada, 2007
3. Raghavan D, Leibl SA, Scher HI, et al: Radiotherapy for Stage B Prostate Cancer: Contemporary Approaches Using External Beam Radiotherapy, Principles and Practice of Genito-Urinary Oncology. Philadelphia, PA, Lippincott-Raven, 1997, pp 517-526
4. Boehmer D, Maingon P, Poortmans P, et al: Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol 79:259269, 2006
5. PisanskyTM: External-beam radiotherapy for localized prostate cancer. N Engl J Med 355:1583-1591, 2006
6. Thompson I, Thrasher JB, Aus G, et al: Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177:2106-2131, 2007
7. Dimeo F: Radiotherapy-related fatigue and exercise for cancer patients: A review of the literature and suggestions for future research. Front Radiat Ther Oncol 37:49-56, 2002
8. Hickok JT, Roscoe JA, Morrow GR, et al: Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104:1772-1778, 2005
9. Jereczek-Fossa BA, Marsiglia HR, Orecchia R: Radiotherapy-related fatigue. Crit Rev Oncol Hema-tol 41:317-325, 2002
10. Monga U, Kerrigan AJ, Thornby J, et al: Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Invest 7:178-185, 1999
11. Monga U, Kerrigan AJ, Thornby J, et al: Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. J Rehabil Res Dev 42:391-399, 2005
12. Penson DF, Litwin MS: The physical burden of prostate cancer. Urol Clin North Am 30:305-313, 2003
13. Segal RJ, Reid RD, Courneya KS, et al: Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21: 1653-1659, 2003
14. Landers J: Maximums based on reps. Nat Strength Cond Assoc J 6:60-61, 1985
15. Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties, applications, and interpretation. Health Qual Life Outcomes 1:79, 2003
16. Cella D, Eton DT, Lai JS, et al: Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24:547-561, 2002
17. Bristol DR: Designing clinical trials for two-sided multiple comparisons with a control. Control Clin Trials 10:142-152, 1989
18. Littlewood TJ, Kallich JD, San Miguel J, et al: Efficacy of darbepoetin alfa in alleviating fatigue and the effect of fatigue on quality of life in anemic patients with lymphoproliferative malignancies. J Pain Symptom Manage 31:317-325, 2006
19. Bennett CL, Silver SM, Djulbegovic B, et al: Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299:914-924, 2008
20. Windsor PM, Nicol KF, Potter J: A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101:550-557, 2004
21. Culos-Reed SN, Robinson JL, Lau H, et al: Benefits of a physical activity intervention for men with prostate cancer. J Sport Exerc Psychol 29:118-127, 2007
22. American College of Sports Medicine Position Stand: The recommended quantity and quality of exercise for developing and maintaining cardiorespi-ratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 30:975-991, 1998
23. Galvão DA, Nosaka K, Taaffe DR, et al: Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38:2045-2052, 2006
24. Galvao DA, Taaffe DR, Spry N, et al: Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis 10:340-346, 2007
25. American College of Sports Medicine: ACSM's Guidelines for Exercise Testing and Prescription (ed 7). Philadelphia, PA, Lippincott, Williams & Wilkins, 2006